The estimated Net Worth of Peter T Slover is at least $408 Mille dollars as of 20 August 2013. Mr. Slover owns over 4,680 units of Sophiris Bio Inc stock worth over $0 and over the last 11 years he sold SPHS stock worth over $0. In addition, he makes $408,329 as Chief Financial Officer at Sophiris Bio Inc.
Sign up
Mr. Slover SPHS stock SEC Form 4 insiders trading
Peter has made over 1 trades of the Sophiris Bio Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently he bought 4,680 units of SPHS stock worth $19,890 on 20 August 2013.
The largest trade he's ever made was buying 4,680 units of Sophiris Bio Inc stock on 20 August 2013 worth over $19,890. On average, Peter trades about 585 units every 0 days since 2013. As of 20 August 2013 he still owns at least 4,680 units of Sophiris Bio Inc stock.
You can see the complete history of Mr. Slover stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Peter Slover biography
Peter T. Slover is the Chief Financial Officer, Director of Sophiris Bio Inc., since January 2013. He served as our Head of Finance and Principal Accounting Officer from April 2012 to January 2013. From April 2004 to April 2012, Mr. Slover held a variety of significant management positions at Anadys Pharmaceuticals, Inc., a public biotechnology company, including Vice President, Finance and Operations, a position that he held from July 2009 to April 2012, Senior Director, Finance and Corporate Controller, Senior Manager, Financial Reporting and Internal Controls and Manager of Financial Reporting. Prior to joining Anadys, Mr. Slover was an auditor at KPMG LLP, where he spent seven years in public accounting. Mr. Slover is a Certified Public Accountant in the State of California. He received a B.S. in Business Administration from Shippensburg University.
What is the salary of Peter Slover?
As the Chief Financial Officer of Sophiris Bio Inc, the total compensation of Peter Slover at Sophiris Bio Inc is $408,329. There are 3 executives at Sophiris Bio Inc getting paid more, with Randall Woods having the highest compensation of $637,543.
How old is Peter Slover?
Peter Slover is 40, he's been the Chief Financial Officer of Sophiris Bio Inc since 2012. There are 7 older and no younger executives at Sophiris Bio Inc. The oldest executive at Sophiris Bio Inc is Lars Ekman, 70, who is the Chairman of the Board.
What's Peter Slover's mailing address?
Peter's mailing address filed with the SEC is 1258 Prospect St, La Jolla, CA 92037, USA.
Insiders trading at Sophiris Bio Inc
Over the last 11 years, insiders at Sophiris Bio Inc have traded over $592,052 worth of Sophiris Bio Inc stock and bought 1,642,180 units worth $8,144,540 . The most active insiders traders include Capital, Llc Boxer Asset Ma..., Capital, Llc Boxer Asset Ma... e William R Rohn. On average, Sophiris Bio Inc executives and independent directors trade stock every 155 days with the average trade being worth of $0. The most recent stock trade was executed by Randall E Woods on 19 September 2018, trading 10,000 units of SPHS stock currently worth $26,300.
What does Sophiris Bio Inc's logo look like?
Complete history of Mr. Slover stock trades at Sophiris Bio Inc
Sophiris Bio Inc executives and stock owners
Sophiris Bio Inc executives and other stock owners filed with the SEC include:
-
Randall Woods,
President, Chief Executive Officer, Director -
Allison Hulme,
Director -
Randall E. Woods,
Pres, CEO & Director -
Peter Slover,
Chief Financial Officer -
Lars Ekman,
Chairman of the Board -
Gerald Proehl,
Independent Director -
John Geltosky,
Independent Director -
Iain R. Mant Esq.,
Corp. Sec. -
Dr. James Joseph Beesley,
Sr. Director of Investor Relations -
Dr. Samuel R. Denmeade M.D.,
Chief Scientific Officer & Member of the Scientific Advisory Board -
James L Heppell,
Director -
Joseph L Turner,
Director -
Capital, Llc Boxer Asset Ma...,
-
William R Rohn,
Director -
Capital, Llc Boxer Asset Ma...,